Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christina Schmidt et al.|Blood|2022Cited by 100
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A. Herbst, Sascha Dietrich, Berit J. Brinkmann et al.|Nature Communications|2022Cited by 42
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy targetLaura Llaó Cid, Martina Seiffert, Jkl Wong et al.|Nature Communications|2025Cited by 14
Integrative multi-omics identifies regulatory and exhausted T cell types and novel immunotherapy targets in CLL lymph nodesMartina Seiffert, Elı́as Campo, Laura Llaó Cid et al.|Research Square|2024Cited by 0